Literature DB >> 24911475

Twitter storm forces Chimerix's hand in compassionate use request.

Michael Goodman.   

Abstract

Mesh：

Substances：

Year:  2014        PMID： 24911475     DOI： 10.1038/nbt0614-503

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  1 in total

1.  TeGenero fiasco prompts regulatory rethink.

Authors:  Cormac Sheridan
Journal:  Nat Biotechnol       Date:  2006-05       Impact factor: 54.908
  1 in total
  3 in total

1.  Right-to-try laws and individual patient "compassionate use" of experimental oncology medications: A call for improved provider-patient communication.

Authors:  Michael Hoerger
Journal:  Death Stud       Date:  2015-08-27

Review 2.  Exploring patient and family involvement in the lifecycle of an orphan drug: a scoping review.

Authors:  Andrea Young; Devidas Menon; Jackie Street; Walla Al-Hertani; Tania Stafinski
Journal:  Orphanet J Rare Dis       Date:  2017-12-22       Impact factor: 4.123

3.  Going "social" to access experimental and potentially life-saving treatment: an assessment of the policy and online patient advocacy environment for expanded access.

Authors:  Tim K Mackey; Virginia J Schoenfeld
Journal:  BMC Med       Date:  2016-02-02       Impact factor: 8.775
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.